(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

PUTTING RARE DISEASES PATIENTS FIRST!

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

PUTTING RARE DISEASES PATIENTS FIRST!

ST13

US500000086800228

Class

41

Filing

86800228

Registration

5046943

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

32

Latest update

02/10/2026

Trademark type

Word

Nice classes

41

Filing date

10/27/2015

Registration date

09/20/2016

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/21/2026

Last transaction

02/10/2026

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

10/29/2015

First use in commerce

10/29/2015

Drawing code

4

Owner type

99

Owner location

San Diego, CA, US

Examiner

EULIN, INGRID C

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Putting Rare Diseases Patients First!

Representatives

Norm J. Rich FOLEY & LARDNER LLP

Technical classification

Nice Classes

Class 41

Vienna Codes

No Vienna codes available.

Goods and services

Class 41

Educational servicesproviding educational instruction in the form of classesseminarsworkshopswebinarsteleconferenceswebcasts in the fields of clinical trials and the drug development process to patients with rare diseasesparents of children with rare diseases and distributing course material in connection therewith

Publications

History of USPTO decisions and trademark events.

32 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

01/21/2026

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

01/21/2026

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

01/21/2026

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

01/16/2026

E89R

TEAS SECTION 8 & 9 RECEIVED

10/10/2025

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

09/20/2025

NA85

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

07/01/2022

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

07/01/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

07/01/2022

E815

TEAS SECTION 8 & 15 RECEIVED

01/26/2022

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

09/20/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

09/20/2016

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

08/16/2016

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

08/13/2016

SUPC

STATEMENT OF USE PROCESSING COMPLETE

07/19/2016

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

07/15/2016

IUAF

USE AMENDMENT FILED

06/20/2016

EISU

TEAS STATEMENT OF USE RECEIVED

06/20/2016

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

06/14/2016

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/19/2016

PUBO

PUBLISHED FOR OPPOSITION

04/19/2016

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/30/2016

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/10/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/10/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/10/2016

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/10/2016

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

02/22/2016

GNRT

NON-FINAL ACTION E-MAILED

02/22/2016

CNRT

NON-FINAL ACTION WRITTEN

02/22/2016

DOCK

ASSIGNED TO EXAMINER

02/18/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/30/2015

NWAP

NEW APPLICATION ENTERED

10/30/2015

Continuous trademark protection

Get notified about every new filing that threatens PUTTING RARE DISEASES PATIENTS FIRST! or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.